Deft Blog · From the Peptides course, Module 8

No, You Didn't Lose 40% Muscle: The Most Repeated Error in the GLP-1 Conversation

You've seen the sentence: "40% of the weight you lose on Ozempic is muscle." It's wrong — and it's wrong in the most instructive way in this whole field: it mislabels the category.

The sentence appears everywhere: in protein-powder marketing, in clinic ads for "muscle-preserving" add-on therapies, in frightened posts from people who have done genuinely well on these medicines. It has a number in it, which makes it feel sourced. It is built from a real number. And it misnames what that number measures, in the direction that sells the most product.

The true fact underneath it

In the body-composition substudy of the STEP 1 trial of semaglutide, roughly 38–40% of the weight lost was lean mass. That much is verified. Everything goes wrong in the next step, where "lean mass" quietly becomes "muscle."

Lean mass is not muscle. On a body-composition scan, "lean mass" is everything that is not fat or bone: skeletal muscle, yes — plus organs, water, blood, and connective tissue. The 2025 joint advisory from four US medical and nutrition bodies (the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society) estimates that skeletal muscle is roughly half of lean body mass. Apply that to the substudy and actual muscle comes out at roughly 20% of the weight lost — half the headline figure. The headline doubles the muscle number by renaming the category.

The numbers nobody quotes alongside it

• Tirzepatide's figure is lower. In the SURMOUNT-1 body-composition substudy, about 25% of the weight lost was lean mass — and about 75% was fat.
• It's not a GLP-1 quirk. Losing roughly a quarter of weight as fat-free mass is the long-standing pattern across weight-loss methods. In SURMOUNT-1, the placebo group lost lean mass in about the same proportion as the tirzepatide group. What these drugs change is the total amount and the speed of loss — not the existence of a lean component.
• The balance improves. Because fat falls faster than lean, the proportion of the body that is lean typically improves on these medicines. Lean loss is a real thing to guard against. It is not the wasting story the headline sells.

So the corrected sentence is less frightening and more useful: on these drugs, roughly a quarter to two-fifths of the weight lost is lean mass depending on the drug and the study, roughly half of that lean is muscle, and the same pattern shows up in every large weight loss ever measured. Which raises the obvious question: what actually protects the lean part?

What actually helps — and it's not a powder with a scary ad

The same 2025 joint advisory gives population-level guidance for people on GLP-1 therapy, and it is unglamorous: protein in the range of roughly 1.2–1.6 grams per kilogram of body weight per day (a practical target of about 80–120 grams a day for many adults), paired with structured resistance training at least three times a week, plus regular aerobic activity. The advisory states plainly that protein alone, without the resistance training, is likely inadequate.

Read those figures the way this course teaches you to read all figures: as published guidance for a population, to be individualised with your own clinician or dietitian against your health, your kidneys, your medications, and your life. They are not a personal prescription.

One more instrument matters: the bathroom scale alone can't tell you any of this. A single total can't distinguish fat loss (the goal) from lean loss (the risk), and a plateau week can hide either. Body-composition trends — read over weeks, under consistent conditions — are the practical way to watch the split, which is why the advisory treats monitoring as part of the response rather than an afterthought.

The question that cuts through all of it

Who profits from this statistic being frightening?

The "40% muscle" sentence is not an innocent rounding error; it's a sales instrument. It surfaces in the funnels of sellers whose next click is a product — a powder, a peptide add-on, a clinic package. That doesn't make lean-mass loss imaginary: it is real, it matters most for older adults, and protein plus resistance training plus monitoring is a genuine, evidence-backed response. It does mean the frightening version of the number should be graded the way you'd grade any claim in this field — by checking what it measures, what it renames, and who benefits from the rename.

Lean mass is not muscle. Forty is not forty when half of it was never muscle to begin with. And the fix was never a product with your fear in its ad copy — it's protein, resistance training, and watching the trend.